SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Genetown
Astria Therapeutics Announces Pricing of $64 Million Underwritten Offering - October 12, 2023
October 11, 2023
 · 
5 min read
Business
Astria Therapeutics Announces Exclusive Worldwide License Agreement with Ichnos Sciences for OX40 Portfolio
October 11, 2023
 · 
11 min read
Business
ICHNOS SCIENCES ENTERS LICENSING AGREEMENT FOR OX40 ANTAGONIST MONOCLONAL ANTIBODY PORTFOLIO WITH ASTRIA THERAPEUTICS
October 11, 2023
 · 
3 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 03, 2023
October 3, 2023
 · 
1 min read
Genetown
Astria Therapeutics to Participate in Upcoming Investor Conferences
September 6, 2023
 · 
1 min read
Drug Development
Astria Therapeutics Announces Publication of STAR-0215 Preclinical Data in the Journal of Pharmacology and Experimental Therapeutics
August 31, 2023
 · 
7 min read
Genetown
Astria Therapeutics to Present Patient Survey Data at Upcoming 2023 HAEi Regional EMEA Conference
August 25, 2023
 · 
1 min read
Business
Astria Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update
August 7, 2023
 · 
12 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 02, 2023
August 2, 2023
 · 
1 min read
FDA
Astria Therapeutics Receives Fast Track Designation for STAR-0215 for the Treatment of Hereditary Angioedema
July 20, 2023
 · 
7 min read
Load More